Genetic Epidemiology, Translational Neurogenomics, Psychiatric Genetics and Statistical Genetics Laboratories investigate the pattern of disease in families, particularly identical and non-identical twins, to assess the relative importance of genes and environment in a variety of important health problems.
QIMR Home Page
GenEpi Home Page
About GenEpi
Publications
Contacts
Research
Staff Index
Collaborators
Software Tools
Computing Resources
Studies
Search
GenEpi Intranet
PMID
22500942
TITLE
Association of OPRD1 polymorphisms with heroin dependence in a large case-control series.
ABSTRACT
Genes encoding the opioid receptors (OPRM1, OPRD1 and OPRK1) are obvious candidates for involvement in risk for heroin dependence. Prior association studies commonly had samples of modest size, included limited single nucleotide polymorphism (SNP) coverage of these genes and yielded inconsistent results. Participants for the current investigation included 1459 heroin-dependent cases ascertained from maintenance clinics in New South Wales, Australia, 1495 unrelated individuals selected from an Australian sample of twins and siblings as not meeting DSM-IV criteria for lifetime alcohol or illicit drug dependence (non-dependent controls) and 531 controls ascertained from economically disadvantaged neighborhoods in proximity to the maintenance clinics. A total of 136 OPRM1, OPRD1 and OPRK1 SNPs were genotyped in this sample. After controlling for admixture with principal components analysis, our comparison of cases to non-dependent controls found four OPRD1 SNPs in fairly high linkage disequilibrium for which adjusted P values remained significant (e.g. rs2236857; OR 1.25; P=2.95×10(-4) ) replicating a previously reported association. A post hoc analysis revealed that the two SNP (rs2236857 and rs581111) GA haplotype in OPRD1 is associated with greater risk (OR 1.68; P=1.41×10(-5) ). No OPRM1 or OPRK1 SNPs reached more than nominal significance. Comparisons of cases to neighborhood controls reached only nominal significance. Our results replicate a prior report providing strong evidence implicating OPRD1 SNPs and, in particular, the two SNP (rs2236857 and rs581111) GA haplotype in liability for heroin dependence. Support was not found for similar association involving either OPRM1 or OPRK1 SNPs.
© 2012 The Authors, Addiction Biology © 2012 Society for the Study of Addiction.
DATE PUBLISHED
2014 Jan
HISTORY
PUBSTATUS PUBSTATUSDATE
aheadofprint 2012/04/13
entrez 2012/04/17 06:00
pubmed 2012/04/17 06:00
medline 2014/08/19 06:00
AUTHORS
NAME COLLECTIVENAME LASTNAME FORENAME INITIALS AFFILIATION AFFILIATIONINFO
Nelson EC Nelson Elliot C EC Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA Queensland Institute of Medical Research, Australia National Drug and Alcohol Research Centre, University of New South Wales, Australia Burnet Institute, Centre for Health Policy, Programs and Economics, School of Population Health, University of Melbourne, Australia.
Lynskey MT Lynskey Michael T MT
Heath AC Heath Andrew C AC
Wray N Wray Naomi N
Agrawal A Agrawal Arpana A
Shand FL Shand Fiona L FL
Henders AK Henders Anjali K AK
Wallace L Wallace Leanne L
Todorov AA Todorov Alexandre A AA
Schrage AJ Schrage Andrew J AJ
Madden PA Madden Pamela A F PA
Degenhardt L Degenhardt Louisa L
Martin NG Martin Nicholas G NG
Montgomery GW Montgomery Grant W GW
INVESTIGATORS
JOURNAL
VOLUME: 19
ISSUE: 1
TITLE: Addiction biology
ISOABBREVIATION: Addict Biol
YEAR: 2014
MONTH: Jan
DAY:
MEDLINEDATE:
SEASON:
CITEDMEDIUM: Internet
ISSN: 1369-1600
ISSNTYPE: Electronic
MEDLINE JOURNAL
MEDLINETA: Addict Biol
COUNTRY: United States
ISSNLINKING: 1355-6215
NLMUNIQUEID: 9604935
PUBLICATION TYPE
PUBLICATIONTYPE TEXT
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
COMMENTS AND CORRECTIONS
REFTYPE REFSOURCE REFPMID NOTE
Cites J Anxiety Disord. 2010 Jan;24(1):49-54 19775865
Cites Int Rev Neurobiol. 2009;88:199-222 19897079
Cites Curr Opin Pharmacol. 2010 Feb;10(1):1-5 20015687
Cites Genome Res. 2010 Mar;20(3):311-9 20032171
Cites J Neurosci. 2010 Mar 31;30(13):4735-45 20357124
Cites J Neurosci. 2010 Apr 21;30(16):5617-28 20410114
Cites Drug Alcohol Depend. 2010 May 1;108(3):166-71 20338697
Cites Ann Neurol. 2010 May;67(5):559-69 20437553
Cites PLoS One. 2010;5(5):e10693 20502693
Cites FEBS J. 2010 Jul;277(13):2815-29 20528919
Cites Sci Signal. 2010;3(131):ra54 20647592
Cites Eur J Neurosci. 2010 Aug;32(4):625-31 20626460
Cites Addict Biol. 2010 Oct;15(4):434-47 20731628
Cites Nucleic Acids Res. 2011 Jan;39(Database issue):D876-82 20959295
Cites Neuron. 2011 Jan 13;69(1):120-31 21220103
Cites Proc Natl Acad Sci U S A. 2011 May 31;108(22):9268-73 21576462
Cites ACS Chem Neurosci. 2010 Feb 17;1(2):146-54 22816017
Cites Nat Genet. 2005 Nov;37(11):1217-23 16244653
Cites AAPS J. 2005;7(2):E353-60 16353915
Cites Proc Natl Acad Sci U S A. 2005 Dec 27;102(52):19208-13 16365317
Cites Hum Mol Genet. 2006 Mar 15;15(6):807-19 16476706
Cites Biol Psychiatry. 2007 Jun 1;61(11):1244-51 17157823
Cites PLoS Genet. 2006 Dec;2(12):e190 17194218
Cites Am J Hum Genet. 2007 Sep;81(3):559-75 17701901
Cites Drug Alcohol Depend. 2007 Oct 8;90(2-3):159-65 17416470
Cites Mol Psychiatry. 2008 May;13(5):531-43 17622222
Cites Br J Pharmacol. 2008 May;154(2):384-96 18414400
Cites Alcohol Alcohol. 2008 Sep-Oct;43(5):505-15 18477577
Cites Neuropsychopharmacology. 2002 Jan;26(1):106-14 11751037
Cites Am J Hum Genet. 2004 Apr;74(4):765-9 14997420
Cites Proc Natl Acad Sci U S A. 2004 May 4;101(18):7187-92 15107502
Cites J Med Chem. 2004 Jun 3;47(12):2969-72 15163177
Cites Mol Psychiatry. 2004 Jun;9(6):547-9 15037869
Cites J Stud Alcohol. 1994 Mar;55(2):149-58 8189735
Cites Soc Psychiatry Psychiatr Epidemiol. 1998 Feb;33(2):80-8 9503991
Cites Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9608-13 9689128
Cites Arch Gen Psychiatry. 1998 Nov;55(11):967-72 9819064
Cites Arch Gen Psychiatry. 1998 Nov;55(11):973-9 9819065
Cites Am J Med Genet. 1999 Oct 15;88(5):462-4 10490698
Cites Bioinformatics. 2005 Jan 15;21(2):263-5 15297300
Cites Heredity (Edinb). 2005 Sep;95(3):221-7 16077740
Cites Am J Med Genet B Neuropsychiatr Genet. 2008 Oct 5;147B(7):1159-66 18314870
Cites Biol Psychiatry. 2009 Jan 15;65(2):169-74 18950747
Cites Genes Brain Behav. 2008 Oct;7(7):720-9 18518925
Cites PLoS One. 2009;4(2):e4410 19198656
Cites Alcohol Clin Exp Res. 2009 Apr;33(4):729-39 19183129
Cites Physiol Rev. 2009 Oct;89(4):1379-412 19789384
Cites Biol Psychiatry. 2009 Oct 15;66(8):777-84 19576572
Cites J Biol Chem. 2005 Sep 23;280(38):32618-24 16046395
GRANTS
GRANTID AGENCY COUNTRY
K05 AA017688 NIAAA NIH HHS United States
R01 DA017305 NIDA NIH HHS United States
R01 DA017305 NIDA NIH HHS United States
GENERAL NOTE
KEYWORDS
KEYWORD
Association study
OPRD1
OPRK1
OPRM1
case-control
heroin dependence
MESH HEADINGS
DESCRIPTORNAME QUALIFIERNAME
Adult
Case-Control Studies
Control Groups
Female
Genetic Association Studies
Genetic Predisposition to Disease genetics
HapMap Project genetics
Haplotypes genetics
Heroin Dependence genetics
Humans genetics
Linkage Disequilibrium genetics
Logistic Models genetics
Male genetics
Middle Aged genetics
New South Wales genetics
Polymorphism, Single Nucleotide genetics
Principal Component Analysis genetics
Receptors, Opioid genetics
Receptors, Opioid, delta genetics
Twins genetics
SUPPLEMENTARY MESH
GENE SYMBOLS
CHEMICALS
REGISTRYNUMBER NAMEOFSUBSTANCE
0 OPRD1 protein, human
0 Receptors, Opioid
0 Receptors, Opioid, delta
OTHER ID's
OTHERID SOURCE
NIHMS387380 NLM
PMC3867542 NLM